[Coumarin necrosis].
D000074:Acenocoumarol / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001941:Breast Diseases; D003374:Coumarins / Q000009:adverse effects*; D048909:Diabetes Complications; D005260:Female; D005534:Foot Diseases; D006470:Hemorrhage / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced* / Q000628:therapy; D009765:Obesity; D011655:Pulmonary Embolism / Q000188:drug therapy*; D013923:Thromboembolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy*; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D003374:Coumarins; D000074:Acenocoumarol
Cumarinnekrosen.